Researchers in @scisignal discovered a signaling mechanism that prevents T helper 17 cells from adopting pathogenic states linked to autoimmunity, potentially informing future efforts to treat autoimmune diseases such as multiple sclerosis.
Learn more on #WorldMSDay: https://t.co/1OhYNgsoSa
Join our lab at Karolinska Institutet in beautiful Stockholm 🇸🇪!
We are recruiting an enthusiastic postdoc to dissect tumor-reactive T cells in cancer patients and help advance immunotherapies, collaborating closely with clinical researchers.
Apply here: https://t.co/5xP1RPZgi2
Bianchi et al find that the FCRL3 receptor is expressed upon repetitive activation of human memory T lymphocytes & limits their responses via inhibitory pathways. This study identifies FCRL3 as a regulator of highly differentiated memory T cells in humans https://t.co/9Mqs3xWivc
This year’s medicine laureate Shimon Sakaguchi discovered a new class of T cells.
Sakaguchi was swimming against the tide in 1995, when he made a key discovery. At the time, many researchers were convinced that immune tolerance only developed due to potentially harmful immune cells being eliminated in the thymus, through a process called central tolerance.
Sakaguchi showed that the immune system is more complex and discovered a previously unknown class of immune cells, which protect the body from autoimmune diseases.
#NobelPrize
Researchers have discovered a signaling mechanism that prevents T helper 17 cells from adopting pathogenic states linked to #autoimmunity, potentially informing future efforts to treat autoimmune diseases such as multiple sclerosis. @BRFAA_IIBEAA https://t.co/dUgcIhO3Zs
Researchers have discovered a signaling mechanism that prevents T helper 17 cells from adopting pathogenic states linked to #autoimmunity, potentially informing future efforts to treat autoimmune diseases such as multiple sclerosis. @SciSignal https://t.co/cGYBFxB3ow
Polyfunctional, cytotoxic, TCR-biased CD4 T cells, targeting NY-ESO-1, offer great promise for adoptive cell transfer in patients @ScienceAdvances
https://t.co/VJcDKouFU7
🚨Today in @CellCellPress, we show that RNA splicing factor mutations in myeloid cancers generate splicing-derived public neoantigens targetable by #TCR tx. Amazing collaboration co-led by @AbdelWahablab, @bradleybio, and @KlebanoffLab. #Tcellpower
https://t.co/5fycZiLEWg
Terminal differentiation and persistence of effector regulatory T cells essential for preventing intestinal inflammation @NatImmunol
https://t.co/eV6Gl0mK5Q
Top 4 misconceptions about science
1. It fills knowledge-gaps (discoveries are unknown unknowns)
2. It proceeds along a straightforward path (discoveries are not predictable)
3. It looks for answers (new questions are crucial)
4. It is only rational (requires night science leaps)
Thrilled to share our latest work on broadening T cell help for developing better flu vaccines @ScienceMagazine@sarah_h_ross
Grateful for Mark Davis’s invaluable mentorship @StanfordMed@stanfordimmuno https://t.co/qeY0bQhXyU 1/n